A clinical scoring system for predicting tumor recurrence after percutaneous radiofrequency ablation for 3 cm or less hepatocellular carcinoma

Preoperative prediction of tumor recurrence after radiofrequency ablation (RFA) in patients with early hepatocellular carcinoma (HCC) is helpful for clinical decision-making before treatment. A total of 162 patients with HCC of 3 cm or less who were completely ablated by percutaneous RFA were divide...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yong Zhu, He, Kun, Huang, Rui Qin, Liu, Li Wen, Ye, Shao Wei, Qian, Jun Lin, Peng, Peng, Luo, Qi Jie, Wang, Ze Liang, Hu, Ze Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050297/
https://www.ncbi.nlm.nih.gov/pubmed/33859298
http://dx.doi.org/10.1038/s41598-021-87782-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050297/
https://www.ncbi.nlm.nih.gov/pubmed/33859298
http://dx.doi.org/10.1038/s41598-021-87782-y

Ejemplares similares